Skip To The Main Content

2019 PDA Drug Delivery of Injectables Conference

Nov 12 - Nov 13, 2019
Taipei City, Taiwan

Impact of Digitilization on Pharmaceuticals, Manufacturing and Patient Care

  • Conference
  • Asia-Pacific
Program Highlights

Stay Informed to get the updates on speakers, session details, exhibitor information, courses, and more!

Come as a group and bring along a colleague for FREE!
Register 3 people from the same organization as a group (at the same time) for the Conference and receive the 4th registration free.


The progress made in electronics, sensor technology and data processing opened new fields in the healthcare world. This allows better control of manufacturing processes, the use of artificial intelligence tools for better and faster selection of data and it enables to directly connect patients and healthcare providers. It seems possible that the quality of each product container can be traced to the manufacturing process and with the knowledge of patient behavior a more patient & specific treatment will be possible.

The goal of this conference is to show:

  • How Primary packaging and fill-finish process can interact
  • Devices like pens, auto-injectors and wearables with electronic features
  • Current status of digital technologies in healthcare
  • Digital health applications for patients in hospital and home care
  • Advantages to the Patient


  • Day 1
  • Day 2
  • Tuesday, 12 November

    *Agenda subject to change*

    08:00 - 18:00
    Registration Open

    09:00 - 09:30
    Opening Remarks
    Herbert Chung-Hsiun Wu,
    PhD, Co-Chair, BPIPO
    Markus Bauss, Co-Chair, SHL Connect

    09:30 - 10:30
    P1: Opening Plenary
    This session highlights digitalization developments in pharmaceutical manufacturing and personalized patient care.
    Moderator: Georg Roessling, PhD, Senior Consultant, Business Development Asia, PDA

    09:30 - 10:00
    Future of Packaging Materials - Reduce Your Footprint on the Environment
    Yves Steffen, Novartis

    10:00 - 10:30
    Revolutionizing Personalized Patient Care Through Digital Therapeutics: An Industry Perspective
    Ed Deng, Health2Sync

    10:30 - 11:00
    Coffee Break and Exhibition

    11:00 - 12:30
    P2: From Primary Packaging to Devices
    The role and importance of primary packaging and drug delivery devices now and the trends for the future.
    Moderator: Robin Hwang, CEO and President, ICP Consulting Corp.

    11:00 - 11:30
    A CDMO Perspective on Modern Drug Delivery: The Journey From Drug Substance to Drug Product
    Thomas Schoenknecht, LONZA

    11:30 - 12:00
    Micropump Device for Continuous Subcutaneous Administration of Drug Formulations
    Robert Kriftner
    , Sensile Medical AG

    12:00 - 12:30
    Digital Design - A Look at the Future Transformation of Device Design
    Ron Forster, PhD, Amgen

    12:30 - 13:30
    Networking Lunch

    Concurrent Tracks

    13:30 - 15:00
    TRACK A1: Manufacturing: Modern Concepts for Facility and Filling Operations
    The manufacturing environment and the machines are essential for the manufacturing of pharmaceutical products. This session gives examples of best current practice.
    Moderator: Robin Hwang, CEO and President, ICP Consulting Corp.

    13:30 - 14:00
    Modern Pharmaceutical Manufacturing Site
    Speaker from EirGenix

    14:00 - 14:30
    Challenges and Solutions for Small Batch Production Filling Lines
    Matthias Angelmaier
    Robert Bosch Packaging Technology GmbH

    14:30 - 15:00
    Smart Medical Device: Connected Health - Manufacturing Perspective
    Alexander Mayer, 
    Harro Hoefliger
    Christian Kollecker, Harro Hoefliger

    13:30 - 15:00
    TRACK B1: Devices: Increase Product Value
    In this session, new developments in injection devices are presented and the value of modern injection systems for improved patient acceptance is described.
    Moderator: Markus Bauss, Managing Director, SHL Connect

    13:30 - 14:00
    Drug Delivery Meeting Automotive - Device Platform Design
    Thomas Mayer, Sonceboz

    14:00 - 14:30
    Differentiating Drug Values in Market by Injection Devices
    Edgar Yeh
    , CC Biotechnology Corporation

    14:30 - 15:00
    Possible Improvements of Current PFS Safety Injection of Flu Vaccines
    Lee Lin Lee,
    MedicalChain International Corp.

    15:00 - 15:30
    Coffee Break and Exhibition

    Concurrent Tracks

    15:30 - 18:00
    TRACK A2: Digital Manufacturing
    In this session, the concept of digitalization in production is presented. Impact on process control, documentation, overall efficiency and product quality is discussed.
    Moderator: Robin Hwang, CEO and President, ICP Consulting

    15:30 - 16:00
    Process Modeling and Digital Twins in Biologics Manufacturing
    Sei Murakami, PhD, Hitachi Ltd.

    16:00 - 16:45
    Digital Manufacturing Increasing Production Efficiency While Increasing Product Quality
    Matsumoto MamoruHitachi Ltd.

    16:45 - 17:15
    IIoT Enables Pharmaceutical Safety by Realtime Cold Chain Management
    David YangAdvantech Co., Ltd.

    17:15 - 18:00
    Panel Discussion on Digital Manufacturing

    • What are the elements for the digital manufacturing environment?
    • Simulation and virtual reality
    • Sensors and data collection
    • Data and Processing/Trend analysis
    • The benefits

    15:30 - 18:00
    TRACK B2: Devices with Connectivity
    This session describes the change from devices to connected devices and what the advantages for patients in home care can be.
    Moderator: Markus Bauss, Managing Director, SHL Connect

    15:30 - 16:00
    Driving Better Patient Outcome with Connectivity
    Adam Shain MSAptar Pharma

    16:00 - 16:30
    Design, Development and Value Proposition of Connected Drug Delivery Technology
    Christian Keller
    , SHL Group
    Chelsea WilliamsSHL Group

    16:30 - 17:00
    Successful Implementation of Connected Drug Delivery Devices: Lessons Learned from Diabetes
    Arnaud Guillet
    , Biocorp

    17:00 - 17:30
    The Benefits of Aerosol Drug Delivery Device and its Digitalization
    Jackie Tieng,
     MicroBase Technology Corp.

    17:30 - 18:00
    Questions and Answers/Discussion


  • Wednesday, 13 November

    *Agenda subject to change*

    08:00 - 17:30
    Registration Open

    Concurrent Tracks

    09:00 - 10:15
    TRACK A3: Manufacturing/Technology: Role of Primary Packaging Components and Device/Track and Trace/Assembly
    This session shows how primary packaging components can interact with the filling machines, document the process and ensure total quality control.
    Moderator: Wayne Wu, President, PDA Taiwan Chapter

    09:00 - 09:30
    Measuring the Impact of Uniquely Identified Containers During and Automated Inspection Process
    Andrea Sardella, PhD, Stevanato-Group

    09:30 - 10:00
    Enhancing Patient Safety and Product Quality through Technology and Digitalization
    Kwang Kok Li
    , West Pharma

    10:00 - 10:15
    Questions and Answers/Discussion

    09:00 - 10:15
    TRACK B3: Digital Health Applications Enabling Personalized Patient Care
    Connected devices help patients better manage their own health and care at home, which also contributes to better adherence. This session gives examples how this can be used for monitoring and diagnostic purposes but also how the internet of things can contribute for data exchange between patients at home and healthcare providers. 
    Moderator: Chi-Feng Chang, PhD, Deputy Director, BPIPO

    09:00 - 09:30
    Digital Mobile Diagnostic Devices Facilitating Self-Management of Health and Diseases
    Alan Tsai, iXensor

    09:30 - 10:00
    Medical IOT Leading to Patient-Centric Services
    Jerry Hsu
    , Asus Life

    10:00 - 10:15
    Questions and Answers/Discussion

    10:15 - 10:45
    Coffee Break and Exhibition

    Concurrent Sessions

    10:45 - 12:30

    Track A4: Manufacturing/Technology
    The final step of manufacturing a drug delivery device is the assembly of the primary packaging with the device. This is a crucial step and it only is successful in terms of quality if clear specification for the primary packaging components and the filling have been considered. This session describes the testing and manufacturing steps which are necessary.
    Moderator:  Wayne Wu President, PDA Taiwan Chapter

    10:45 - 11:15
    Container Integrity Testing
    Heinz Wolf, PTI Packaging Technologies

    11:15 - 11:45
    Qualification of Test Methods: Leak Simulation and Flow Test
    Henry Lu
    , Optek

    11:45 - 12:15
    Optimization of Material and Process Flow for Production of Auto Injector Sub-Assemblies
    Lucy Chung, SHL
    Gilbert Fluetsch,

    12:15 - 12:30
    Questions and Answers/Discussion

    10:45 - 12:30
    TRACK B4: Special Device Applications
    This session has presentations which deal with special topics. One is about handling of highly potent drugs and the other presentation covers the whole development process of a syringe for ophthalmic use. The very challenging quality requirements and their technical implementation are described. The session ends with a regulatory related topic addressing essential performance requirements and control strategy for combination products.
    Moderator: Shih-Chong Tsai, PhD, Executive Director, Institute of Biologics, Development Center for Biotechnology

    10:45 - 11:15
    Close System Transfer Device (CSTD) Use with Oncology Drugs and Biologics
    Lana Shiu, Amgen

    11:15 - 11:45
    Visisure® From Concept to Approval: A Low Volume High Accuracy Syringe
    Marc Rohrschneider, Novartis

    11:45 - 12:15
    Essential Performance Requirements and the Control Strategy for Combination Product (PFS) from Design to Manufacture
    Shu-Chen Chen, Genentech

    12:15 - 12:30
    Questions and Answers/Discussion

    12:30 - 13:30
    Networking Lunch

    13:30 - 15:30
    P3: Digital Health
    Healthcare costs are increasing, and people look for ways to reduce costs by integrating digital health technologies into current healthcare infrastructure. This session gives a broader and global perspective of digital health. Highlighting efforts of governments but also showing opportunities for the healthcare systems and advantages for patients.
    Moderator: Ed Deng, Co-Founder & CEO, Health2Sync

    13:30 - 14:00
    How Do Governments Worldwide Promote Digital Health?
    Lily Wong, PwC Taiwan

    14:00 - 14:30
    Investing in Digital Health: Global Perspective, Local Implications
    Joseph Mocanu, Verge HealthTech Fund

    14:30 - 15:00
    US Regulatory Perspectives of Connective Devices
    Lening Shen,
    Lana Shiu, Amgen

    15:00 - 15:30
    How Mobile Technologies are Transforming Healthcare?
    Jessy Kang, PhD, Smart Ageing Tech

    15:30 - 16:00
    Coffee Break and Exhibition

    16:00 - 17:30
    P4: Panel Discussion: Future of Drug Delivery and Digitalization in Health Care in Asia
    In many Asian countries, the patients still receive their injectables from healthcare professionals and the home care treatment does not yet play a significant role. But healthcare costs and improved patient care will lead to developments where patients receive user friendly application systems like autoinjectors, pens and wearables. In addition, concepts of microelectronics and digitalization in combination with the pharmaceutical product will be play a role. There will be opportunities to directly receive data from the patient and have a direct access to therapy and diagnostic data from the patient. The technologies by itself are there and the potential advantages for patient management and health care costs are given or at least can be estimated. This panel discussion wants to address the dynamic of this process and the implications on patient and healthcare system. What are the real advantages? What is the impact on the health care system? What will be the drivers? What will the situation be in 10-30 years from today?
    Moderator: Herbert Chung-Hsiun Wu, PhD, Co-Chair, BPIPO, Markus Bauss, Co-Chair, SHL Connect and Marc Rohrschneider, Novartis


    Ron Forster, Amgen
    Anthony JonesSanofi
    Joseph Mocanu, Verge HealthTech Fund
    Lana Shiu, Amgen
    Lily Wong, PwC Taiwan

    Closing Remarks
    Georg Roessling, PhD, Senior Consultant, Business Development Asia, PDA

Additional Information

  • Who Should Attend

    More information coming soon.

Got a Question? We have answers

Contact Us


PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

Grand Victoria Hotel

No. 168, Jingye 4th Road, Zhongshan District
Taipei City, Taiwan

Grand Victoria Hotel
  • Accommodations

    A block of rooms have been reserved for meeting participants.  The rate is NT$4,500  inclusive of taxes and breakfast.  Reservations must be secured by Friday, October 11, 2019.  After this date, reservation can be made on a space and rate available basis only.

    To reserve a room at the group rate please email [email protected] and include that you are booking to attend PDA Taiwan 2019.

    Individual Cancellation

    Please be aware that obtaining and canceling hotel reservations is the responsibility of the meeting registrant. Individuals will be responsible for payment of their own cancellation fees. The cancellation policy is 3 days in advance of arrival unless otherwise specified on your reservation information.

    Letter of Invitation

    If you are requesting an invitation letter please note that you are required to complete the registration process including the final payment before the letter can be provided.  Please email [email protected] to request a letter of invitation. 

  • Amenities

How to Get Here

By Air

The Taiwan Taoyuan International Airport (TPE) is approx. 1hr (46.6km) from the hotel.

The Taipei Songshan Airport (TSA) is approx. 14 minutes (6.2km) from the hotel.

By Car

Traveling north on the Zhongshan North-South Freeway

Move into the right lane after the Linkou Interchange and get onto the high elevated section of the freeway at the 18KM marker. Exit the freeway at the Tiding Boulevard Interchange and turn left onto Tiding Boulevard. Turn left at Lequn 2nd Road then right onto Zhifu Road to reach the hotel.

Traveling north on Freeway No. 2

After passing the off ramp for Freeway No. 5 get into the right lane and exit at the Nangang Interchange. Take theoff ramp down to Huandong Boulevard and proceed to Lequn 2nd Road. Turn left, then right at Zhifu Road to reach the hotel

*The hotel has ample underground parking.

Other Options

By Bus

Dozens of bus lines pass the Grand Victoria Hotel including lines 21, 222, 247, 267, 286, 287, 620, 646, 72, 902, Red 2, Brown 16, Blue 26, Blue 7 and others. Get off at the Miramar stop and we are only a 3-minute walk away.


On the MRT, take the Wenhu Line to Jiannan Road and exit the Number 3 Exit then walk to the hotel.


Registration Fees

Regular Price
Registration Type  
Member $599 USD
Non-member $799 USD
Government $399 USD
Student $399 USD
Young Professional Member  $399 USD

Letter of Invitation

If you are requesting an invitation letter please note that you are required to complete the registration process including the final payment before the letter can be provided.  Please email [email protected] to request a letter of invitation.

* For this member type or discount, online registration is not available, please contact [email protected].

Group Registration Discount: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.

GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.

CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].


Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information

Featured Exhibitors

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Media Partners

Related Events


Program Inquiries
  • Leah Oleszewski
    Tel: +1 (301) 656-5900 ext. 128
Exhibition Inquiries
  • Tony Chan
    Assistant Director
Training Course Inquiries

Tel: +1 (301) 656-5900
[email protected]

Tel: +49 (0) 30 43 655 08-10
[email protected]

Registration Customer Care

Tel: +1 (301) 656-5900 ext. 115
[email protected]

PDA Members Save Substantially